Elmiron Lawsuit Lawyers in New York City
If you have suffered eye damage, vision problems, or blindness after taking prescription drug Elmiron to treat Interstitial Cystitis, also known as Bladder Pain Syndrome, you may be eligible to receive monetary compensation to cover medical bills, lost wages, lost earning capacity if you are no longer able to work, pain and suffering, and more.
Drug manufacturers are obligated to put warnings on their medications to alert potential users about any known side effects, so patients and their doctors can make the most informed treatment decisions. When pharmaceutical companies fail to warn about the risks, they can be held liable for injuries caused by their drug.
Elmiron Eye Damage
Elmiron is the only FDA-approved drug prescribed to treat Interstitial Cystitis, which is an ailment that affects the urinary tract system and causes abdominal and pelvic pain. Also known as Bladder Pain Syndrome, Interstitial Cystitis mostly affects women. Pain in the abdomen, bladder, and pelvis can be chronic or intermittent, and the condition often leads to frequent urination.
Recent studies have found that patients who used Elmiron as prescribed by their doctors have developed Maculopathy, a retinal disease and leading cause of blindness in the United States.
Early symptoms of Maculopathy include:
- Having difficulty reading, with blurry vision
- Inability for the eyes to adjust to the darkness
- Difficulty seeing close objects
- Straight lines appearing curved
- Vision that becomes dim or dullness of colors
- Loss of peripheral vision and night vision
- Dark spots in the field of vision
Medical experts are now recommending that patients who have used the drug Elmiron have an ophthalmic examination for early detection of maculopathy.
Please note: Douglas & London is a law firm. If you have taken Elmiron and have symptoms of Maculopathy, please contact a medical professional.
Are You Eligible to File an Elmiron Lawsuit?
You may have sufficient grounds to file an Elmiron eye damage lawsuit if:
- You took prescription Elmiron as directed by a doctor on a daily basis for six months or longer.
- Within one year of stopping the drug, you were diagnosed with: age-related macular degeneration, macular retinopathy, maculopathy, pigmentary maculopathy, retinal dystrophy, retinopathy, or scotoma.
What Is Elmiron Used For?
Since 1996, doctors have prescribed Elmiron (pentosan polysulfate sodium) for the improvement of bladder and pelvic pain associated with Interstitial Cystitis, an ailment in the urinary tract system affecting an estimated four to 12 million Americans. Most patients take three 100 mg doses a day for at least one month, though many people do not see improvement until the six to nine-month mark. It is not uncommon for people to use Elmiron for years or even decades, with doses up to 1,500 mg prescribed for severe flares.
Elmiron is manufactured by Janssen Pharmaceuticals. Studies have shown that patients taking Elmiron, particularly in higher doses, are at increased risk of maculopathy, a progressive eye disease that can lead to vision loss. While maculopathy is irreversible, it can potentially be managed through early detection and treatment.
